Activation of human TLR4 by endotoxin binding to MD-2

内毒素与 MD-2 结合激活人 TLR4

基本信息

  • 批准号:
    6814118
  • 负责人:
  • 金额:
    $ 10.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-01 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This five-year proposal is designed to promote a career as an academic clinician investigator in the fields of immunology and infectious diseases. The candidate will complete fellowship training in infectious diseases and be appointed to the faculty of the Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases. Her career development will be mentored by Dr. David S. Stephens, Distinguished Professor of Medicine, and Professor of Microbiology and Immunology, and Epidemiology, and Director Division of Infectious Diseases. This research plan will be conducted in Dr. Stephens' laboratory which has a long and successful track record in microbial pathogenesis and molecular genetics. The Toll-like receptor 4 (TLR4), together with its accessory protein MD-2, and endotoxin are responsible for initiating much of the inflammatory response in sepsis caused by meningococci and other gram-negative bacteria. Previous work in the laboratory has identified an important role for meningococcal KDO2-lipid A in activation of the TLR4/MD-2 receptor complex. The hypothesis is that MD-2 is a specific determinant of TLR4 activation and that the KDOz-lipid A endotoxin structure is critically important for direct binding to MD-2. The importance of KDO in binding to MD-2, other endotoxin structural requirements for binding to MD-2 and the activation of TLR4 will be investigated. Specific Aim 1: Determine the meningococcal KDO2-lipid A structure required for interaction with the human adaptor protein MD-2 using genetically and biochemically defined meningococcal lipooligosaccharides. Specific Aim 2: Determine the general endotoxin structure required for extracellular activation of TLR4 via the accessory protein MD-2. Significance. Understanding the role of MD-2 in TLR4 activation by endotoxin may impact therapeutic interventions that modify the inflammatory immune response. This proposal will identify the components of bacterial endotoxin which are most efficiently recognized by MD-2 and presented to TLR4. The study of other diseases (e.g. atherosclerosis, inflammatory bowel disease, and asthma) with inflammatory components which are mediated by the activation of TLR4 and MD-2 may also benefit from this work.
描述(由申请人提供):这个为期五年的提案旨在促进职业生涯作为一个学术临床研究人员在免疫学和传染病领域。 候选人将完成传染病研究金培训,并被任命为埃默里大学医学院传染病系医学系的教员。 她的职业发展将由大卫博士指导。斯蒂芬斯,医学的杰出教授,微生物学和免疫学,流行病学教授,传染病部主任。 该研究计划将在Stephens博士的实验室进行,该实验室在微生物发病机制和分子遗传学方面有着长期而成功的记录。 Toll样受体4(TLR 4)及其辅助蛋白MD-2和内毒素负责启动脑膜炎球菌和其他革兰氏阴性菌引起的脓毒症中的大部分炎症反应。实验室先前的工作已经确定了脑膜炎球菌KDO 2-脂质A在TLR 4/MD-2受体复合物活化中的重要作用。 假设MD-2是TLR 4活化的特异性决定因素,并且KDOz-脂质A内毒素结构对于与MD-2的直接结合至关重要。 将研究KDO在与MD-2结合中的重要性、与MD-2结合的其他内毒素结构要求以及TLR 4的活化。 具体目标1:确定脑膜炎球菌KDO 2-脂质A结构所需的相互作用与人类衔接蛋白MD-2使用遗传和生物化学定义的脑膜炎球菌脂寡糖。 具体目的2:确定通过辅助蛋白MD-2细胞外激活TLR 4所需的一般内毒素结构。 意义 了解MD-2在内毒素激活TLR 4中的作用可能会影响改变炎症免疫反应的治疗干预。该建议将鉴定MD-2最有效识别并呈递给TLR 4的细菌内毒素组分。 对具有由TLR 4和MD-2的活化介导的炎症组分的其他疾病(例如动脉粥样硬化、炎症性肠病和哮喘)的研究也可以从这项工作中受益。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shanta M Zimmer其他文献

Shanta M Zimmer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shanta M Zimmer', 18)}}的其他基金

Quantifying Contact Rates and Mixing Patterns in School Age Children
量化学龄儿童的接触率和混合模式
  • 批准号:
    8325411
  • 财政年份:
    2011
  • 资助金额:
    $ 10.82万
  • 项目类别:
Quantifying Contact Rates and Mixing Patterns in School Age Children
量化学龄儿童的接触率和混合模式
  • 批准号:
    8237128
  • 财政年份:
    2011
  • 资助金额:
    $ 10.82万
  • 项目类别:
Activation of human TLR4 by endotoxin binding to MD-2
内毒素与 MD-2 结合激活人 TLR4
  • 批准号:
    7391561
  • 财政年份:
    2004
  • 资助金额:
    $ 10.82万
  • 项目类别:
Activation of human TLR4 by endotoxin binding to MD-2
内毒素与 MD-2 结合激活人 TLR4
  • 批准号:
    7198160
  • 财政年份:
    2004
  • 资助金额:
    $ 10.82万
  • 项目类别:
Activation of human TLR4 by endotoxin binding to MD-2
内毒素与 MD-2 结合激活人 TLR4
  • 批准号:
    7029689
  • 财政年份:
    2004
  • 资助金额:
    $ 10.82万
  • 项目类别:
Activation of human TLR4 by endotoxin binding to MD-2
内毒素与 MD-2 结合激活人 TLR4
  • 批准号:
    6908206
  • 财政年份:
    2004
  • 资助金额:
    $ 10.82万
  • 项目类别:

相似海外基金

Molecular mechanisms underlying glial inflammatory responses to Neisseria meningitidis: A pilot study
神经胶质细胞对脑膜炎奈瑟菌炎症反应的分子机制:一项初步研究
  • 批准号:
    10452116
  • 财政年份:
    2022
  • 资助金额:
    $ 10.82万
  • 项目类别:
Molecular mechanisms underlying glial inflammatory responses to Neisseria meningitidis: A pilot study
神经胶质细胞对脑膜炎奈瑟菌炎症反应的分子机制:一项初步研究
  • 批准号:
    10551245
  • 财政年份:
    2022
  • 资助金额:
    $ 10.82万
  • 项目类别:
Identification of bactericidal antibody specificities for the development of novel broad-coverage vaccine candidates against Neisseria meningitidis
鉴定杀菌抗体特异性,用于开发针对脑膜炎奈瑟菌的新型广泛覆盖候选疫苗
  • 批准号:
    10404598
  • 财政年份:
    2021
  • 资助金额:
    $ 10.82万
  • 项目类别:
Acquisition of gonococcal denitrification apparatus in the Neisseria meningitidis urethritis clade
脑膜炎奈瑟菌尿道炎分支中淋菌反硝化装置的获得
  • 批准号:
    10317302
  • 财政年份:
    2021
  • 资助金额:
    $ 10.82万
  • 项目类别:
Acquisition of gonococcal denitrification apparatus in the Neisseria meningitidis urethritis clade
脑膜炎奈瑟菌尿道炎分支中淋菌反硝化装置的获得
  • 批准号:
    10448441
  • 财政年份:
    2021
  • 资助金额:
    $ 10.82万
  • 项目类别:
Identification of bactericidal antibody specificities for the development of novel broad-coverage vaccine candidates against Neisseria meningitidis
鉴定杀菌抗体特异性,用于开发针对脑膜炎奈瑟菌的新型广泛覆盖候选疫苗
  • 批准号:
    10256250
  • 财政年份:
    2021
  • 资助金额:
    $ 10.82万
  • 项目类别:
Defining the link between viral co-infection and the invasive potential of Neisseria meningitidis
确定病毒合并感染与脑膜炎奈瑟菌侵袭潜力之间的联系
  • 批准号:
    449574
  • 财政年份:
    2020
  • 资助金额:
    $ 10.82万
  • 项目类别:
    Studentship Programs
Antimicrobial susceptibility and penicillin resistance mechanism in the Japanese clinical isolates of Neisseria meningitidis
日本临床分离脑膜炎奈瑟菌的耐药性及青霉素耐药机制
  • 批准号:
    20K08818
  • 财政年份:
    2020
  • 资助金额:
    $ 10.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Revealing processes that confer immunity against nasal colonization by Neisseria meningitidis
揭示赋予脑膜炎奈瑟菌鼻定植免疫力的过程
  • 批准号:
    408154
  • 财政年份:
    2018
  • 资助金额:
    $ 10.82万
  • 项目类别:
    Studentship Programs
The CRISPR/Cas system in Neisseria meningitidis and its potential role in host cell adhesion
脑膜炎奈瑟菌中的CRISPR/Cas系统及其在宿主细胞粘附中的潜在作用
  • 批准号:
    405974664
  • 财政年份:
    2018
  • 资助金额:
    $ 10.82万
  • 项目类别:
    Priority Programmes
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了